RE: CHAT GPT23 Oct 2025 17:00
I asked it a very simple question and it's the only answer we care about
The short answer: yes, in theory the proprietary delivery platform developed by Avacta Therapeutics (via its pre|CISION® technology) could be worth billions — but turning that theoretical potential into a reality involves a lot of risk. Here’s a breakdown of how and why.